RecruitingNot ApplicableNCT05758805

Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal and Persistent AF (ESO-SAFE-HP-RF)

Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal and Persistent AF


Sponsor

Quovadis Associazione

Enrollment

51 participants

Start Date

Jan 8, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This pilot, prospective, interventional, monocentric, independent, and no-profit clinical trial aims to investigate and evaluate the proportion, acute and chronic characteristics, and outcomes of esophageal thermal injury (ETI) in AF ablation using a high-power, short-duration (HP-SD) setting with contact force (CF) sensing tip ablation catheter in standard clinical practice. The main questions it aims to answer are: * Evaluate the acute proportion of the ETI assessed by the mini-invasive esophagoscopy pre and post-procedure. In addition, clinical evaluations at 3, 6, and 12 months from the procedure are foreseen. * Evaluate the contribution of the factors influencing RF procedure (contact force, impedance, RF power, RF time) on ETI development. * Describe the relationship between the esophageal temperature (continuous monitoring) and ETI development.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating whether a particular type of heart ablation catheter (used to treat irregular heart rhythms) causes less injury to the esophagus — the tube running behind the heart — compared to standard catheters. Ablation uses heat to correct abnormal electrical pathways causing atrial fibrillation. **You may be eligible if...** - You have atrial fibrillation (an irregular heartbeat) - Your doctor has recommended a catheter ablation procedure using a radiofrequency catheter with contact-force sensing technology - You are able to sign the consent form **You may NOT be eligible if...** - Your heart's pumping function is significantly reduced (ejection fraction below 45%) - You have a blood clot in the left side of your heart - You have severe heart failure (NYHA class III or IV) - Your heart is greatly enlarged (atrial diameter over 50mm) - You have moderate or severe heart valve problems, a pacemaker or defibrillator, severe kidney failure, uncontrolled thyroid problems, or a life expectancy under 1 year Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEmini-invasive esophagoscopy

mini-invasive esophagoscopy assessment of esophageal thermal injury (ETI) after an AF ablation session in an HP-SD setting, and with a tip CF sensing ablation catheter

DEVICEHP-SD AF ablation by a CF sensing catheter

AF ablation session in an HP-SD setting and with a tip CF sensing ablation catheter


Locations(1)

SOD di Cardiologia e Aritmologia

Ancona, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05758805


Related Trials